Key Financial Data Of Group

Kringle Pharma,Inc. - Filing #7290853

Concept 2023-10-01 to
2024-09-30
As at
2024-09-30
2022-10-01 to
2023-09-30
As at
2023-09-30
2021-10-01 to
2022-09-30
As at
2022-09-30
2020-10-01 to
2021-09-30
As at
2021-09-30
2019-10-01 to
2020-09-30
As at
2020-09-30
Key financial data of group
Business results of group
Net sales
80,038,000 JPY
69,250,000 JPY
391,829,000 JPY
289,756,000 JPY
467,616,000 JPY
Ordinary profit (loss)
-754,961,000 JPY
-852,660,000 JPY
-330,339,000 JPY
-299,676,000 JPY
-116,341,000 JPY
Net assets
2,108,192,000 JPY
2,021,702,000 JPY
2,789,187,000 JPY
2,506,149,000 JPY
2,188,521,000 JPY
Total assets
2,757,113,000 JPY
2,618,657,000 JPY
3,208,691,000 JPY
2,635,625,000 JPY
2,350,242,000 JPY
Net assets per share
306.87
363.45
517.75
578.17
599.97
Basic earnings (loss) per share
-118.21
-158.46
-68.33
-72.51
-106.70
Diluted earnings per share
Equity-to-asset ratio
0.758 xbrli:pure
0.766 xbrli:pure
0.868 xbrli:pure
0.951 xbrli:pure
0.931 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-661,166,000 JPY
-689,095,000 JPY
15,796,000 JPY
-560,922,000 JPY
-146,461,000 JPY
Net cash provided by (used in) investing activities
-121,363,000 JPY
-120,875,000 JPY
-254,383,000 JPY
JPY
JPY
Net cash provided by (used in) financing activities
838,233,000 JPY
69,164,000 JPY
603,112,000 JPY
595,904,000 JPY
2,082,523,000 JPY
Cash and cash equivalents
1,816,943,000 JPY
1,761,239,000 JPY
2,502,046,000 JPY
2,137,520,000 JPY
2,102,538,000 JPY
Number of employees
15 xbrli:pure
13 xbrli:pure
12 xbrli:pure
11 xbrli:pure
9 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.